I think BP knows leronlimab is the real deal...
Post# of 148166
He has no interest whatsoever in working with another company right now. With CytoDyn and leronlimab he has the possibility to write medical history...
At some point, CytoDyn can either ink a long-term partnership with IncellDx or acquire it for its diagnostics, but there is no need to rush things and act immediately IMO.